Oppenheimer adjusted its outlook on Albemarle Corporation (NYSE:ALB), a global developer of lithium and other chemical solutions. The firm's analyst, Colin W. Rusch, reduced the price target to $123 ...
Deutsche Bank lowered the firm’s price target on Albemarle (ALB) to $85 from $105 and keeps a Hold rating on the shares. The company’s 2025 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results